Cargando…
Enzyme replacement therapy for Anderson-Fabry disease: A complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies
BACKGROUND: Anderson-Fabry disease (AFD) is an X-linked recessive inborn error of glycosphingolipid metabolism caused by a deficiency of alpha-galactosidase A. Renal failure, heart and cerebrovascular involvement reduce survival. A Cochrane review provided little evidence on the use of enzyme replac...
Autores principales: | El Dib, Regina, Gomaa, Huda, Ortiz, Alberto, Politei, Juan, Kapoor, Anil, Barreto, Fellype |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351840/ https://www.ncbi.nlm.nih.gov/pubmed/28296917 http://dx.doi.org/10.1371/journal.pone.0173358 |
Ejemplares similares
-
Biomarkers in Anderson–Fabry Disease
por: Simonetta, Irene, et al.
Publicado: (2020) -
Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011) -
The distribution of hypertrophy in anderson fabry disease
por: Sado, Daniel M, et al.
Publicado: (2011) -
Anderson-Fabry disease in heart failure
por: Akhtar, M. M., et al.
Publicado: (2018) -
Clinical prodromes of neurodegeneration in Anderson-Fabry disease
por: Löhle, Matthias, et al.
Publicado: (2015)